234 related articles for article (PubMed ID: 8691139)
1. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.
Dyall R; Fremont DH; Jameson SC; Nikolić-Zugić J
J Exp Med; 1996 Jul; 184(1):253-8. PubMed ID: 8691139
[TBL] [Abstract][Full Text] [Related]
2. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
[TBL] [Abstract][Full Text] [Related]
3. T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity.
Janković V; Remus K; Molano A; Nikolich-Zugich J
J Immunol; 2002 Aug; 169(4):1887-92. PubMed ID: 12165513
[TBL] [Abstract][Full Text] [Related]
4. The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding.
Huard R; Dyall R; Nikolić-Zugić J
Int Immunol; 1997 Nov; 9(11):1701-7. PubMed ID: 9418131
[TBL] [Abstract][Full Text] [Related]
5. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
6. A molecular basis for how a single TCR interfaces multiple ligands.
Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
[TBL] [Abstract][Full Text] [Related]
7. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
[TBL] [Abstract][Full Text] [Related]
8. The H-2Kk MHC peptide-binding groove anchors the backbone of an octameric antigenic peptide in an unprecedented mode.
Kellenberger C; Roussel A; Malissen B
J Immunol; 2005 Sep; 175(6):3819-25. PubMed ID: 16148128
[TBL] [Abstract][Full Text] [Related]
9. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution.
Miley MJ; Messaoudi I; Metzner BM; Wu Y; Nikolich-Zugich J; Fremont DH
J Exp Med; 2004 Dec; 200(11):1445-54. PubMed ID: 15557346
[TBL] [Abstract][Full Text] [Related]
11. Functional evidence that conserved TCR CDR alpha 3 loop docking governs the cross-recognition of closely related peptide:class I complexes.
Messaoudi I; LeMaoult J; Metzner BM; Miley MJ; Fremont DH; Nikolich-Zugich J
J Immunol; 2001 Jul; 167(2):836-43. PubMed ID: 11441090
[TBL] [Abstract][Full Text] [Related]
12. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
13. A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I.
Kalergis AM; Goyarts EC; Palmieri E; Honda S; Zhang W; Nathenson SG
J Immunol Methods; 2000 Feb; 234(1-2):61-70. PubMed ID: 10669770
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein.
Takahashi H; Houghten R; Putney SD; Margulies DH; Moss B; Germain RN; Berzofsky JA
J Exp Med; 1989 Dec; 170(6):2023-35. PubMed ID: 2479705
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complex.
Madhurantakam C; Duru AD; Sandalova T; Webb JR; Achour A
PLoS One; 2012; 7(3):e32805. PubMed ID: 22431983
[TBL] [Abstract][Full Text] [Related]
18. CTL escape viral variants. I. Generation and molecular characterization.
Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
[TBL] [Abstract][Full Text] [Related]
19. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
20. Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.
Ciatto C; Tissot AC; Tschopp M; Capitani G; Pecorari F; Plückthun A; Grütter MG
J Mol Biol; 2001 Oct; 312(5):1059-71. PubMed ID: 11580250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
